These are independent reviews of the products mentioned, but TIME receives a commission when purchases are made through affiliate links at no additional cost to the purchaser.
Novo Nordisk’s Ozempic, Wegovy, and Rybelsus are all part of the same category of drugs called semaglutides, which originally were developed to treat type 2 diabetes—in part by helping people shed pounds better than any previous medication and therefore control their blood sugar. But it wasn’t until recently that their weight-loss feature propelled them to be among the most in-demand prescription medications. Still, the drugs aren’t without controversy over inappropriate use and side effects, including stomach and intestinal issues, that have prompted a warning from the FDA.
More Must-Reads from TIME
- Breaking Down the 2024 Election Calendar
- How Ukraine Beat Russia in the Battle of the Black Sea
- The Reintroduction of Kamala Harris
- Long COVID Looks Different in Kids
- What a $129 Frying Pan Says About America’s Eating Habits
- The 1 Heart-Health Habit You Should Start When You’re Young
- Cuddling Might Help You Get Better Sleep
- The 50 Best Romance Novels to Read Right Now